Targeting poly(ADP-ribose) polymerase and the c-Myb-regulated DNA damage response pathway in castration-resistant prostate cancer.
about
Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapyResistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate CancerDNA damage response and prostate cancer: defects, regulation and therapeutic implicationsTopBP1 Governs Hematopoietic Stem/Progenitor Cells Survival in Zebrafish Definitive HematopoiesisCombination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions.Molecular pathways and targets in prostate cancerc-Myb Binding Sites in Haematopoietic Chromatin LandscapesEffective use of PI3K inhibitor BKM120 and PARP inhibitor Olaparib to treat PIK3CA mutant ovarian cancer.Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer.Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling.Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level.New advances in genitourinary cancer: evidence gathered in 2014.Micro-RNA-204 Participates in TMPRSS2/ERG Regulation and Androgen Receptor Reprogramming in Prostate Cancer.Combined inhibition of PI3K and PARP is effective in the treatment of ovarian cancer cells with wild-type PIK3CA genes.Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.MYB is a novel regulator of pancreatic tumour growth and metastasis.New targets for resistant prostate cancer.Combining enzalutamide with PARP inhibitors: Pharmaceutically induced BRCAness.BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer.Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate Cancer.ATR/CHK1 inhibitors and cancer therapy.Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer.Transcriptional profile of ethylene glycol monomethyl ether-induced testicular toxicity in rats.Connecting androgen receptor signaling and the DNA damage response: Development of new therapies for advanced prostate cancer.Molecular and cellular mechanisms of castration resistant prostate cancer.Novel anti-androgen receptor signaling agents: Understanding the mechanisms of resistance.Mechanisms and Approaches for Overcoming Enzalutamide Resistance in Prostate Cancer.
P2860
Q26745686-D6188821-C68E-4A08-A20E-24F9DE1867EDQ26751237-16E541C8-5CD6-4D48-B75D-59884062F5D1Q26829155-1F5E2162-39D0-43C6-805E-B334257AEAFFQ27310778-A088A19B-8E08-4340-8B01-A009D34FBBA5Q33798999-E25B53C3-F398-4949-8801-AA61F0C8FA57Q34365632-29003BCF-1440-4ED2-A099-F46B6D0996D3Q35711929-B3D5CFC9-CE68-4914-ABFB-4694B38AEE70Q37022406-7E9C2152-AF18-46CF-82B8-4DC038FD267AQ37564733-469764BF-D07B-4B77-901C-744B8AC73BC4Q37698312-8C917CE5-0B76-4818-BD4D-AB3F7A604811Q38259197-B882BD22-9632-4CBC-B013-B868DCA5F575Q38557894-532A138C-D196-47A7-A866-9C59E721EB82Q38723072-89DC1621-FB87-41A7-9AB3-E873BD2F77CCQ38757645-2758ACB2-DFA4-44C7-9623-5CE72E0BB0F2Q40258666-F33F2973-1096-43CE-B155-712696F6E438Q41842858-E7AAC657-39A7-4C6E-B2FF-16CEB231CC23Q42981809-DDBEADF8-A216-4411-BF36-C20771FECEFDQ47119992-BF774E2D-1B31-4F29-87BB-A8A4EC494F24Q47164964-34C6DF3E-0309-4A99-8B8E-C40000DEC390Q47595568-FA6C658F-A0CD-4B82-BAA1-ABFD14BD8D50Q47622968-D358EDD4-E282-4099-981F-1596EEC61E6BQ48110323-10DB8527-9627-4C28-9F27-61B5DC9D5C37Q51002092-AF4F2EAF-F40C-42FA-BD43-E2FE685F51AAQ52541424-06E0D7A3-037E-44A6-A92D-FA9A762580D8Q52608488-BBC61647-04CF-4419-8FF9-87FDF24A8667Q54949068-0234E4A8-0C37-4A76-979C-F466DF57286FQ55331819-7AA47924-6444-43C9-B908-5E2C1AE149AA
P2860
Targeting poly(ADP-ribose) polymerase and the c-Myb-regulated DNA damage response pathway in castration-resistant prostate cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeting poly(ADP-ribose) pol ...... ion-resistant prostate cancer.
@ast
Targeting poly(ADP-ribose) pol ...... ion-resistant prostate cancer.
@en
type
label
Targeting poly(ADP-ribose) pol ...... ion-resistant prostate cancer.
@ast
Targeting poly(ADP-ribose) pol ...... ion-resistant prostate cancer.
@en
prefLabel
Targeting poly(ADP-ribose) pol ...... ion-resistant prostate cancer.
@ast
Targeting poly(ADP-ribose) pol ...... ion-resistant prostate cancer.
@en
P2093
P2860
P1433
P1476
Targeting poly(ADP-ribose) pol ...... ion-resistant prostate cancer.
@en
P2093
Ana M Aparicio
Bradley Broom
Chengzhen Ren
Eleni Efstathiou
Elsa M Li Ning Tapia
Guang Yang
Hirayama Takahiro
Jianhua Yin
Jianxiang Wang
Ju-Seog Lee
P2860
P356
10.1126/SCISIGNAL.2005070
P577
2014-05-20T00:00:00Z